As per a new agreement, Ampac Fine Chemicals is expected to use Codexis’ proprietary biocatalysis technology in combination with AFC’s existing technologies to reduce cost, increase manufacturing efficiency
Bayer Schering Pharma said that these prospective cohort studies conducted by independent investigators found that the risk for venous thromboembolism (VTE) in Yasmin users is comparable to the
Thermo Fisher Scientific said that as part of a new five-year agreement, the Fisher Clinical Services business of the company will take over responsibility for Lilly’s in-house clinical
As a result of the approval, Erbitux can now be used in Japan in combination with chemotherapy in the first-line-treatment for patients with epidermal growth factor receptor (EGFR)-expressing,
Sanofi-aventis claimed that it would manufacture all of its clopidogrel-containing products for the European markets in the European Union in full compliance with the relevant rules and regulations
ExonHit Therapeutics claimed that EHT 0202 has a novel mechanism of action when compared to existing Alzheimer’s disease therapeutics and stimulates the a-secretase pathway, thus enhancing the production
The clinical trial is taking place at the Hadassah Hebrew University Medical Centre in Jerusalem under an agreement between Immuron and Hadasit, the Medical Centre’s commercialisation arm. Immuron
Initially, Actelion had signed contract with Invida in 2005 and has extended it to market Tracleer in Thailand, Malaysia, Philippines, Vietnam and Hong Kong Invida is expected to
The granted claims of the patent include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents. They are useful in the
Syncom Healthcare’s Dehradun facility is a WHO – GMP compliant manufacturing facility which is situated at Selaqui, near Dehradun in area measuring 4397 sq mts. Syncom Healthcare said
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.